Cargando…
Outcomes of endovascular interventional therapy for primary Budd-Chiari syndrome caused by hepatic venous obstruction
To date, interventional therapy for patients with Budd-Chiari syndrome (BCS) due to hepatic vein obstruction (HVO) has not been standardized in China. In Western countries, BCS primarily occurs due to thrombosis and the majority of patients receive thrombolysis. In China, BCS is mostly caused by the...
Autores principales: | Cheng, De-Lei, Zhu, Nan, Xu, Hao, Li, Cheng-Li, Lv, Wei-Fu, Fang, Wei-Wei, Li, Chuan-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201046/ https://www.ncbi.nlm.nih.gov/pubmed/30402156 http://dx.doi.org/10.3892/etm.2018.6708 |
Ejemplares similares
-
Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd-Chiari syndrome in patients and a rat model
por: Cheng, De-Lei, et al.
Publicado: (2018) -
Review of Budd-Chiari Syndrome
por: Zu, Maoheng, et al.
Publicado: (2020) -
Budd-Chiari syndrome due to hepatic venous web outflow obstruction: percutaneous treatment with balloon angioplasty
por: Metzger, Patrick Bastos, et al.
Publicado: (2021) -
Interventional Treatment of Budd–Chiari Syndrome
por: Rössle, Martin
Publicado: (2023) -
Liver cirrhosis caused by chronic Budd–Chiari syndrome
por: Lin, Mengjie, et al.
Publicado: (2017)